Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grifols Pref | Madrid | Salute | Prodotti farmaceutici | 6,18 Mrd € | 43,3x | 0,01 | 7,90 € | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 40,1% Rialzo | Fai l’upgrade a Pro+ | |
Grifols | Madrid | Salute | Prodotti farmaceutici | 6,18 Mrd € | 43,3x | 0,01 | 9,93 € | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Laborat.Rovi | Madrid | Salute | Prodotti farmaceutici | 3,89 Mrd € | 26,8x | -1,39 | 76 € | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 29,3% Rialzo | Fai l’upgrade a Pro+ | |
Almirall | Madrid | Salute | Prodotti farmaceutici | 1,94 Mrd € | -51,3x | 0,21 | 9,09 € | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,8% Rialzo | Fai l’upgrade a Pro+ | |
Pharma Mar | Madrid | Salute | Prodotti farmaceutici | 1,22 Mrd € | -701x | 4,46 | 69,25 € | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -22,5% Ribasso | Fai l’upgrade a Pro+ | |
Faes Farma | Madrid | Salute | Prodotti farmaceutici | 1,14 Mrd € | 11,8x | 1,58 | 3,69 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 0,3% Rialzo | Fai l’upgrade a Pro+ | |
Natac Natural Ingredients | Madrid | Salute | Prodotti farmaceutici | 273,93 Mln € | -39,2x | 0,63 € | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Laboratorio Reig Jofre | Madrid | Salute | Prodotti farmaceutici | 250,59 Mln € | 26,4x | -12,34 | 3,11 € | -2,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 31% Rialzo | Fai l’upgrade a Pro+ | |
Labiana Health | Madrid | Salute | Prodotti farmaceutici | 17,51 Mln € | -3,9x | 2,48 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -3,2% Ribasso | Fai l’upgrade a Pro+ |